91 – Miscellaneous Abnormalities in Porphyrin Production and Disposal

[1]  M. Doss.  Pathobiochemical transition of secondary coproporphyrinuria to chronic hepatic porphyria in humans , 1980, Klinische Wochenschrift.

[2]  P. Meredith,et al.  The effects of industrial lead poisoning on cytochrome P450 mediated phenazone (antipyrine) hydroxylation , 1977, European Journal of Clinical Pharmacology.

[3]  D. Keppler,et al.  Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in dubin‐johnson syndrome , 2000, Hepatology.

[4]  A. Paller,et al.  Pseudoporphyria induced by celecoxib in a patient with juvenile rheumatoid arthritis. , 2000, The Journal of rheumatology.

[5]  R. Luqmani,et al.  Pseudoporphyria and Nonsteroidal Antiinflammatory Agents in Children with Juvenile Idiopathic Arthritis , 2000, Pediatric dermatology.

[6]  H. Altenkirch.  Multiple chemical sensitivity (MCS)--differential diagnosis in clinical neurotoxicology: a German perspective. , 2000, Neurotoxicology.

[7]  T. Finkel,et al.  Nabumetone induced pseudoporphyria in childhood. , 2000, The Journal of rheumatology.

[8]  J. Faivre,et al.  Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. , 2000, Journal of hepatology.

[9]  T. Simonart,et al.  Treatment of haemodialysis‐associated pseudoporphyria with N‐acetylcysteine: report of two cases , 2000, The British journal of dermatology.

[10]  M. Doss,et al.  Alcohol and porphyrin metabolism. , 2000, Alcohol and alcoholism.

[11]  D. Keppler,et al.  Hepatic Secretion of Conjugated Drugs and Endogenous Substances , 2000, Seminars in liver disease.

[12]  S. Checketts,et al.  Two cases of nabumetone induced pseudoporphyria. , 1999, The Journal of rheumatology.

[13]  B. Lang,et al.  Long-term followup of naproxen-induced pseudoporphyria in juvenile rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[14]  C. Pusey,et al.  Bullous dermatoses in end-stage renal failure: porphyria or pseudoporphyria? , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  H. Westberg,et al.  Porphyrin status in aluminum foundry workers exposed to hexachlorobenzene and octachlorostyrene. , 1999, Archives of environmental health.

[16]  J. Saurat,et al.  Pseudoporphyria induced by nabumetone. , 1999, Journal of the American Academy of Dermatology.

[17]  C. S. Wang,et al.  Hepatocellular carcinoma presenting with acquired porphyria: a case report and review of the literature. , 1999, Changgeng yi xue za zhi.

[18]  C. Magro,et al.  Pseudoporphyria associated with Relafen therapy * , 1999, Journal of cutaneous pathology.

[19]  D. Sasseville,et al.  Pseudoporphyria Induced by Propionic Acid Derivatives , 1999, Journal of cutaneous medicine and surgery.

[20]  Allen,et al.  Pseudoporphyria induced by mefenamic acid , 1998, The British journal of dermatology.

[21]  F. Breier,et al.  Pseudoporphyria cutanea tarda Induced by Furosemide in a Patient Undergoing Peritoneal Dialysis , 1998, Dermatology.

[22]  M. Sarwar,et al.  Mechanistic studies on E.coli 5-aminolaevulinic acid dehydratase. , 1998, Biochemical Society transactions.

[23]  M. Nowicki,et al.  The hereditary hyperbilirubinaemias. , 1998, Bailliere's clinical gastroenterology.

[24]  E. Hernández,et al.  Effect of acute lead treatment on coproporphyrinogen oxidase activity in HepG2 cells. , 1998, Toxicology.

[25]  B. Weiss.  Neurobehavioral properties of chemical sensitivity syndromes. , 1998, Neurotoxicology.

[26]  Beltrami,et al.  Flutamide‐induced pseudoporphyria , 1998, The British journal of dermatology.

[27]  R. Reiter,et al.  Melatonin protects against lipid peroxidation induced by δ-aminolevulinic acid in rat cerebellum, cortex and hippocampus , 1997, Neuroscience.

[28]  R. O'Moore,et al.  Cutaneous abnormalities and metabolic disturbance of porphyrins in patients on maintenance haemodialysis , 1997, Clinical and experimental dermatology.

[29]  H. Bonkovsky,et al.  Multiple chemical sensitivity syndrome and porphyria. A note of caution and concern. , 1997, Archives of internal medicine.

[30]  A. Tefferi,et al.  Environmental chemical exposures and disturbances of heme synthesis. , 1997, Environmental health perspectives.

[31]  A. Brzezinski.  Melatonin in humans. , 1997, The New England journal of medicine.

[32]  M. Kondo,et al.  Symptomatic porphyria secondary to hepatocellular carcinoma , 1997, The British journal of dermatology.

[33]  R. Rietschel,et al.  Oxaprozin-lnduced Pseudoporphyria , 1996 .

[34]  S. González,et al.  Drug photosensitivity, idiopathic photodermatoses, and sunscreens. , 1996, Journal of the American Academy of Dermatology.

[35]  F. Lithner,et al.  The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria , 1996, Journal of internal medicine.

[36]  N. Schoenfeld,et al.  Bullous dermatosis of end-stage renal disease: a possible association between abnormal porphyrin metabolism and aluminium. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  D. Keppler,et al.  Absence of the canalicular isoform of the MRP gene–encoded conjugate export pump from the hepatocytes in Dubin‐Johnson syndrome , 1996, Hepatology.

[38]  F. Coronel,et al.  Effects of recombinant human erythropoietin on porphyrin metabolism in uremic patients on hemodialysis. , 1996, Journal of the American Society of Nephrology : JASN.

[39]  F. Lithner,et al.  Hepatocellular carcinoma in patients from northern Sweden with acute intermittent porphyria: morphology and mutations. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[40]  G. Jori,et al.  The bronze baby syndrome: evidence of increased tissue concentration of copper porphyrins , 1996, Acta paediatrica.

[41]  A. M. del C. Batlle,et al.  Altered 5-aminolevulinic acid metabolism leading to pseudoporphyria in hemodialysed patients. , 1996, The international journal of biochemistry & cell biology.

[42]  M. Panemangalore,et al.  Effects of low oral lead and cadmium exposure and zinc status of heme metabolites in weanling rats. , 1996, International journal of occupational medicine and environmental health.

[43]  L. Leibovici,et al.  Alcohol-induced changes in urinary aminolevulinic acid and porphyrins: unrelated to liver disease. , 1996, Alcohol.

[44]  H. Puy,et al.  Increased delta aminolevulinic acid and decreased pineal melatonin production. A common event in acute porphyria studies in the rat. , 1996, The Journal of clinical investigation.

[45]  A. Varki.  The times they are still a'changing: keeping up with the times. , 1996, The Journal of clinical investigation.

[46]  H. Hamm,et al.  Naproxen-induced pseudoporphyria: appearance of new skin lesions after discontinuation of treatment. , 1995, Scandinavian journal of rheumatology.

[47]  H. Lim,et al.  The porphyrias and hepatocellular carcinoma. , 1995, Dermatologic clinics.

[48]  F. Coronel,et al.  Efficiency of three different hemodialysis membranes for plasma porphyrin removal. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[49]  E. Bechara,et al.  5-Aminolevulinic acid induces iron release from ferritin. , 1995, Archives of biochemistry and biophysics.

[50]  P. Hazen.  Pseudoporphyria in a patient receiving carisoprodol/aspirin therapy. , 1994, Journal of the American Academy of Dermatology.

[51]  X. Causse,et al.  A case of association between hepatocellular carcinoma and porphyria variegata. , 1994, Scandinavian journal of gastroenterology.

[52]  B. Lang,et al.  Naproxen-induced pseudoporphyria in patients with juvenile rheumatoid arthritis. , 1994, The Journal of pediatrics.

[53]  K. Anderson.  Pseudoporphyria versus porphyria cutanea tarda. , 1993, The Journal of pediatrics.

[54]  F. Wojnarowska,et al.  Isotretinoin‐associated pseudoporphyria , 1993, Clinical and experimental dermatology.

[55]  H. Puy,et al.  Decreased nocturnal plasma melatonin levels in patients with recurrent acute intermittent porphyria attacks. , 1993, Life sciences.

[56]  A. Paller,et al.  Pseudoporphyria cutanea tarda: two case reports on children receiving peritoneal dialysis and erythropoietin therapy. , 1992, The Journal of pediatrics.

[57]  K. Gebauer,et al.  5-Fluorouracil-induced pseudoporphyria. , 1992, Australian and New Zealand journal of medicine.

[58]  K. Anderson,et al.  Removal of plasma porphyrins with high-flux hemodialysis in porphyria cutanea tarda associated with end-stage renal disease. , 1992, Journal of the American Society of Nephrology : JASN.

[59]  C. Wilson,et al.  Identical Twins with Sunbed-Induced Pseudoporphyria , 1992, Journal of the Royal Society of Medicine.

[60]  M. Poh-Fitzpatrick,et al.  Peritoneal dialysis does not reduce serum porphyrin levels in porphyria cutanea tarda. , 1992, Nephron.

[61]  M. Doss,et al.  Effect of alcohol on δ-aminolevulinic acid dehydratase and porphyrin metabolism in man , 1991 .

[62]  L. Judd.  Pseudoporphyria due to Cola , 1991, International journal of dermatology.

[63]  A. Vercesi,et al.  Damage to rat liver mitochondria promoted by delta-aminolevulinic acid-generated reactive oxygen species: connections with acute intermittent porphyria and lead-poisoning. , 1991, Biochimica et biophysica acta.

[64]  C. Lim,et al.  Coproporphyrinogen oxidase, protoporphyrinogen oxidase and ferrochelatase activities in iron-overloaded and ethanol-treated rats. , 1990, Biomedical chromatography : BMC.

[65]  D. Bilsland,et al.  Sunbed pseudoporphyria induced by nalidixic acid , 1990, The British journal of dermatology.

[66]  K. Barron,et al.  Naproxen-induced pseudoporphyria: a distinctive photodermatitis. , 1990, The Journal of pediatrics.

[67]  J. R. Person,et al.  Bumetanide-induced pseudoporphyria. , 1990, Journal of the American Academy of Dermatology.

[68]  R. Motley,et al.  Pseudoporphyria due to dyazide in a patient with vitiligo. , 1990, BMJ.

[69]  A. Stenberg.  Pseudoporphyria and sunbeds. , 1990, Acta dermato-venereologica.

[70]  K. McDonald,et al.  Plasma porphyrins in chronic renal failure. , 1990, Nephron.

[71]  K. Reed,et al.  Chlorthalidone-induced pseudoporphyria: clinical and microscopic findings of a case. , 1989, Journal of the American Academy of Dermatology.

[72]  A. McDonagh,et al.  Pseudoporphyria complicating etretinate therapy , 1989, Clinical and experimental dermatology.

[73]  D. Macdonald,et al.  Variegate porphyria associated with hepatocellular carcinoma , 1989, The British journal of dermatology.

[74]  I. Kochevar.  Phototoxicity of nonsteroidal inflammatory drugs. Coincidence or specific mechanism , 1989 .

[75]  K. Kaidbey,et al.  Photosensitizing potential of certain nonsteroidal anti-inflammatory agents. , 1989, Archives of dermatology.

[76]  J. Hawk,et al.  Sunbed‐induced pseudoporphyria , 1989, The British journal of dermatology.

[77]  C. Lim,et al.  Coproporphyrinogen oxidase, protoporphyrinogen oxidase and ferrochelatase activities in human liver biopsies with special reference to alcoholic liver disease. , 1989, Journal of hepatology.

[78]  T. Fitzpatrick.  The validity and practicality of sun-reactive skin types I through VI. , 1988, Archives of Dermatology.

[79]  D. Ooi,et al.  A Ceramic Glazer Presenting with Extremely High Lead Levels , 1988, Human toxicology.

[80]  J. Snape,et al.  Porphyria cutanea tarda resulting from primary hepatocellular carcinoma , 1988, Clinical and experimental dermatology.

[81]  R. Kauppinen,et al.  Acute hepatic porphyria and hepatocellular carcinoma. , 1988, British Journal of Cancer.

[82]  M. Moore,et al.  Lead Effects on the Heme Biosynthetic Pathway Relationship to Toxicity , 1987, Annals of the New York Academy of Sciences.

[83]  M. Doss.  Porphyrinurias and Occupational Disease a , 1987, Annals of the New York Academy of Sciences.

[84]  J. Ballarín,et al.  Pseudoporphyria cutanea tarda associated with cyclosporine therapy. , 1987, Transplantation.

[85]  J. M. Arribas,et al.  Acute-subacute lead poisoning. Clinical findings and comparative study of diagnostic tests. , 1987, Archives of internal medicine.

[86]  F. Collart,et al.  Effect of aluminum on porphyrin metabolism in hemodialyzed patients. , 1987, Nephron.

[87]  A. Batlle,et al.  In inherited porphyrias, lead intoxication is a toxogenetic disorder. , 1987, The International journal of biochemistry.

[88]  M. Moore,et al.  Porphobilinogen deaminase and the synthesis of porphyrin isomers in the Dubin-Johnson syndrome. , 1986, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[89]  D. Henderson,et al.  Naproxen-induced pseudoporphyria. A clinical and ultrastructural study. , 1986, Archives of dermatology.

[90]  B. Fowler,et al.  Effects of lead on the heme biosynthetic pathway in rat kidney. , 1985, Experimental and molecular pathology.

[91]  S. Seubert,et al.  A porphyria cutanea tarda-like distribution pattern of porphyrins in plasma, hemodialysate, hemofiltrate, and urine of patients on chronic hemodialysis. , 1985, The Journal of investigative dermatology.

[92]  H. Miura,et al.  [The effect of an organic gold compound on porphyrin metabolism, with reference to interaction with lead]. , 1985, Sangyo igaku. Japanese journal of industrial health.

[93]  G. Varigos,et al.  PSEUDOPORPHYRIA DUE TO NAPROXEN , 1985, The Lancet.

[94]  V. Carreño,et al.  Porphyria cutanea tarda and hepatocellular carcinoma. Frequency of occurrence and related factors. , 1985, Journal of hepatology.

[95]  L. Wetterberg,et al.  Hepatocellular carcinoma in patients with acute intermittent porphyria. , 2009, Acta medica Scandinavica.

[96]  W. Whetsell,et al.  Porphyrin-heme biosynthesis in organotypic cultures of mouse dorsal root ganglia. Effects of heme and lead on porphyrin synthesis and peripheral myelin. , 1984, The Journal of clinical investigation.

[97]  C. Lim,et al.  Pseudoporphyria associated with consumption of brewers' yeast. , 1984, British medical journal.

[98]  F. Malkinson,et al.  Nalidixic acid-induced photosensitivity in mice: a model for pseudoporphyria. , 1984, The Journal of investigative dermatology.

[99]  C. Pierach,et al.  Pseudo-porphyria in a patient with hepatocellular carcinoma. , 1984, The American journal of medicine.

[100]  D. Bickers,et al.  Porphyria and pseudoporphyria. , 1984, The Journal of investigative dermatology.

[101]  Kikuchi Masakazu,et al.  The in vivo effects of manganese and zinc on δ-aminolevulinic acid dehydratase activity inhibited by lead , 1984 .

[102]  R. Sik,et al.  THE PHOTOTOXIC EFFECT OF BENOXAPROFEN AND ITS ANALOGS ON HUMAN ERYTHROCYTES AND RAT PERITONEAL MAST CELLS , 1983, Photochemistry and photobiology.

[103]  E. Reddi,et al.  Bronze Baby Syndrome: a New Porphyrin-Related Disorder , 1983, Pediatric Research.

[104]  A. Ferioli,et al.  Liquid chromatography of urinary porphyrins for the biological monitoring of occupational exposure to porphyrinogenic substances. , 1983, American journal of industrial medicine.

[105]  P. Disler,et al.  Treatment of hemodialysis-related porphyria cutanea tarda with plasma exchange. , 1982, The American journal of medicine.

[106]  P. Martásek,et al.  Role of the kidneys in porphyrias. , 1982, Nephron.

[107]  K. McColl,et al.  Abnormal haem biosynthesis in chronic alcoholics , 1981, European journal of clinical investigation.

[108]  P. Disler,et al.  Porphyrias and the kidney. , 1981, Nephron.

[109]  J. Lichtenstein,et al.  Porphyria cutanea tarda (PCT) in a patient with chronic renal failure on haemodialysis , 1981, The British journal of dermatology.

[110]  G. Cancarini,et al.  Porphyria cutanea tarda in a haemodialysed patient , 1981, The British journal of dermatology.

[111]  M. Kohakura,et al.  Urinary Coproporphyrin isomers in Rotor's syndrome: A study in eight families , 1981, Hepatology.

[112]  A Smith,et al.  The interaction of human serum albumin and hemopexin with porphyrins. , 1980, Biochimica et biophysica acta.

[113]  J. Bonafé,et al.  [Treatment of a case of porphyria cutanea tarda by plasmapheresis]. , 1980, Annales de dermatologie et de venereologie.

[114]  G. Elder,et al.  Porphyria cutanea tarda during maintenance haemodialysis. , 1980, British medical journal.

[115]  M. Moore,et al.  Acute ethanol ingestion and haem biosnthesis in health subjects , 1980, European journal of clinical investigation.

[116]  M. Poh-Fitzpatrick,et al.  Porphyria cutanea tarda associated with chronic renal disease and hemodialysis. , 1980, Archives of dermatology.

[117]  G. Cancarini,et al.  Porphyria and pseudo-porphyria in hemodialyzed patients. , 1980, The International journal of biochemistry.

[118]  M. Moore,et al.  International review of drugs in acute porphyria--1980. , 1980, The International journal of biochemistry.

[119]  R. Day,et al.  Porphyrins in chronic renal failure. , 1980, Nephron.

[120]  T Kondo,et al.  Metabolic fate of exogenous delta-aminolevulinic acid in Dubin-Johnson syndrome. , 1979, The Journal of laboratory and clinical medicine.

[121]  R. Dymock.  SKIN DISEASES ASSOCIATED WITH RENAL TRANSPLANTATION , 1979, The Australasian journal of dermatology.

[122]  D. Bickers,et al.  Porphyria Cutanea Tarda in Two Patients Treated with Hemodialysis for Chronic Renal Failure , 1978 .

[123]  Grossman Me,et al.  Porphyria cutanea tarda. A rare cutaneous manifestation of hepatic tumors. , 1978 .

[124]  M. Avram,et al.  A comparison of the stimulatory effects of cadmium and zinc on normal and lead-inhibited human erythrocytic delta-aminolevulinic acid dehydratase activity in vitro. , 1978, Toxicology and applied pharmacology.

[125]  M. Brodie,et al.  Alterations in the activity of enzymes of haem biosynthesis in lead poisoning and acute hepatic prophyria. , 1977, Clinical science and molecular medicine.

[126]  S. Snyder,et al.  δ‐Aminolevulinic acid: Influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria , 1977, Annals of neurology.

[127]  G. Urata,et al.  Uroporphyrinogen III cosynthetase in liver and blood in the Dubin-Johnson syndrome. , 1977, The Journal of laboratory and clinical medicine.

[128]  K. Keczkes,et al.  Bullous dermatosis of chronic renal failure , 1976, The British journal of dermatology.

[129]  K. Kuchiba,et al.  Coproporphyrin isomers in Dubin-Johnson syndrome. , 1976, Gastroenterology.

[130]  W. Epstein,et al.  Porphyria-like cutaneous changes induced by tetracycline hydrochloride photosensitization. , 1976, Archives of dermatology.

[131]  A. Wolkoff,et al.  Rotor's syndrome. A distinct inheritable pathophysiologic entity. , 1976, The American journal of medicine.

[132]  D. Barker,et al.  Malignant hepatoma associated with acquired hepatic cutaneous porphyria. , 1976, Archives of dermatology.

[133]  G. Drivas,et al.  The erythrocyte protoporphyrin in chronic renal failure. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[134]  G. Korting.  Über Porphyria-cutanea-tarda-artige Hautveränderungen bei Langzeithämodialysepatienten , 1975 .

[135]  C. Ramsay,et al.  Photosensitivity from nalidixic acid * , 1974, Proceedings of the Royal Society of Medicine.

[136]  W. Epstein,et al.  Cutaneous changes in the porphyrias. A microscopic study. , 1973, Archives of dermatology.

[137]  R. Strand.  Book ReviewPediatric Neuroradiology. , 1973 .

[138]  Strand Lj.  Porphyrins in Dubin-Johnson Syndrome , 1973 .

[139]  A. Wolkoff,et al.  Inheritance of the Dubin-Johnson syndrome. , 1973, The New England journal of medicine.

[140]  N. Kaplowitz,et al.  Coproporphyrin I and 3 excretion in bile and urine. , 1972, The Journal of clinical investigation.

[141]  I. Arias,et al.  Pregnancy, oral contraceptives, and chronic familial jaundice with predominantly conjugated hyperbilirubinemia (Dubin-Johnson syndrome). , 1972, Gastroenterology.

[142]  C. Rimington,et al.  Abnormal excretion of the isomers of urinary coproporphyrin by patients with Dubin-Johnson syndrome in Israel. , 1971, Clinical science.

[143]  U. Seligsohn,et al.  Dubin-Johnson syndrome in Israel. I. Clinical, laboratory, and genetic aspects of 101 cases. , 1970, The Quarterly journal of medicine.

[144]  L. Eales,et al.  Coproporphyrinuria and heart transplantation: its significance. , 1970, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[145]  S. Hernberg,et al.  Enzyme inhibition by lead under normal urban conditions. , 1970, Lancet.

[146]  C. J. Watson,et al.  An analysis of the porphyrins of normal and cirrhotic human liver and normal bile. , 1969, Clinica chimica acta; international journal of clinical chemistry.

[147]  C. J. Stevenson,et al.  PHOTOTOXIC BULLOUS ERUPTIONS DUE TO NALIDIXIC ACID , 1969, British Journal of Dermatology.

[148]  L. Eales.  Coproporphyrinuria and human heart transplantation. , 1968, Lancet.

[149]  P. Koskelo,et al.  Porphyrinuria induced by fasting. , 1968, The New England journal of medicine.

[150]  P. Koskelo,et al.  URINARY EXCRETION OF COPROPORPHYRIN ISOMERS I AND III AND δ‐AMINOLAEVULIC ACID IN NORMAL PREGNANCY AND OBSTETRIC HEPATOSIS , 1968 .

[151]  H. Adlercreutz,et al.  Urinary coproporphyrin isomer distribution in the Dubin-Johnson syndrome. , 1967, Clinical chemistry.

[152]  J. M. French,et al.  Ether-soluble porphyrins in bile, meconium and urine: a new appraisal by microscale counter-current analysis. , 1966, Clinical science.

[153]  A. Eisalo,et al.  Urinary Excretion of Porphyrin Precursors and Coproporphyrin in Healthy Females on Oral Contraceptives , 1966, British medical journal.

[154]  P. Koskelo,et al.  Separation of urinary coproporphyrin isomers 1 and 3 by thin-layer chromatography. Studies in healthy subjects and patients with myocardial infarction. , 1966, Scandinavian journal of clinical and laboratory investigation.

[155]  A. Zelickson.  PHOTOTOXIC REACTION WITH NALIDIXIC ACID. , 1964, JAMA.

[156]  S. Schwartz,et al.  STUDIES OF COPROPORPHYRIN. VIII. REINVESTIGATION OF THE ISOMER DISTRIBUTION IN JAUNDICE AND LIVER DISEASES. , 1964, The Journal of laboratory and clinical medicine.

[157]  S. Schwartz,et al.  STUDIES OF COPROPORPHYRIN. VII. ADAPTATION OF THE ERIKSEN PAPER CHROMATOGRAPHIC METHOD TO THE QUANTITATIVE ANALYSIS OF THE ISOMERS IN NORMAL HUMAN URINE. , 1964, The Journal of laboratory and clinical medicine.

[158]  F. Johnson,et al.  Chronic idiopathic jaundice with unidentified pigment in liver cells; a new clinicopathologic entity with a report of 12 cases. , 1954, Medicine.

[159]  C. Moore,et al.  Characterization of the anemia of chronic renal insufficiency. , 1950, The Journal of clinical investigation.

[160]  G. Cartwright,et al.  Studies on free erythrocyte protoporphyrin, plasma iron and plasma copper in normal and anemic subjects. , 1948, Blood.